Skip to content
TrustList
Exponential AI logo
Artificial Intelligence Company

Exponential AI

A healthcare AI platform company building decision intelligence software for payers and providers

Exponential AI cover

About Exponential AI

Exponential AI is a healthcare AI platform company that builds decision intelligence software intended to help health sector organisations manage increasing demand and complexity. Its central product is a platform called Enso, supported by what it calls a Decision Agent Ecosystem and a wider portfolio of AI solutions designed to be integrated into existing processes. The company recently announced a merger with Rialtic, aimed at improving healthcare payment accuracy, with the combined business offering payers and providers what it describes as an agentic solution covering the payment lifecycle. Exponential AI also partners with consulting firms and technology companies to help deploy and scale its decision intelligence tools across healthcare enterprises, and offers AI strategy consulting alongside its software products. Its chairman, Paul Roma, has previously held leadership roles including at IBM Watson Health and Ciox Health.

Profile written by TrustList from the business's own published information, Sep 2026.

Request a demo or quote from Exponential AI

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

By sending, you agree we may share your request and contact details with the provider once you confirm your email.

Reviews

Write the first review of Exponential AI

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Exponential AI.

Exponential AI alternatives

Similar listings buyers compare against this one.

Offshore software development company providing dedicated engineering teams, AI and cloud services

Microsoft Dynamics and .NET development firm offering support, upgrades and integrations for ERP and retail systems

AI-driven drug discovery platform helping pharma and biotech firms find and license therapeutic assets